This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $23,949.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,713,170 units of the drug Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of December 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $44,524.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,276 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 10, 2024. This award is not associated with a...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract valued at $5,716.26 to prime contractor Amerisourcebergen Drug Corporation. The contract is for the delivery of 4,566,259,566 units of Ondansetron HCL 4 MG Tablets, a medication used to treat nausea and vomiting. This Delivery Order contract has a Firm Fixed Price pricing type and an ultimate completion date of October 30, 2024. Amerisourcebergen Drug Corporation is a major...
This federal contract award, valued at $1,057.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,883,412 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 10, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,566,307,460 tablets of ondansetron hydrochloride 4 mg, a medication used to treat nausea and vomiting, with a ceiling value of $16,135.85. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024 as a firm fixed-price...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,566.08 for the supply of 4,565,520,865 units of the medication ondansetron hydrochloride 4 mg tablets. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is likely part of a...
This federal contract award, valued at $17,269.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, and has an ultimate completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $11,368.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,436 units of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $11,502.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,565,562,970 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant...